Company Profile For Abnova (Taiwan) Corporation
10/19/2005 5:12:11 PM
Abnova Corporation provides scalable, high throughput protein expression and monoclonal antibody production via proprietary technologies, fully automated platforms, industrial-scale infrastructure and state-of-the-art SPF animal facility. Abnova leverages its expertise to advance four principal business activities: custom service, partnership, catalog, and licensing. It is concurrently developing the most comprehensive, antibody bio-tool catalog for the drug discovery and diagnostic industry by focusing on several key areas of human proteins: kinases, apoptosis, receptors, stem cell and plasma proteome. Abnova has two manufacturing sites totaling 44,000 sq ft in Taiwan with 130 employees, and a wholly owned subsidiary, Abnova GmbH, in Germany.